The "Reproductive Genetics Market: By Product Type (Aneuploidy, chromosomal abnormality, single gene disorder, and others), Procedure Type (Pre-Implantation genetic testing, pre-natal screening, pre-implantation genetic testing, and infertility genetic testing), By Technology (Next-Generation Sequencing, polymerase chain reaction, in situ hybridization, and microarray), By Application (Aneuploidy, chromosomal abnormality, single gene disorder, and others), and By Region" report has been added to ResearchAndMarkets.com's offering.
The global reproductive genetics market is expected to reach $50.1 billion by 2032, exhibiting a growth rate of 27.3% during the next five years.
The major factors driving the market include the growing awareness and understanding of genetic disorders among the masses, the rising adoption of preventive healthcare, and the increasing fertility rates leading to a higher uptake of assisted reproductive technologies (ART) such as in-vitro Fertilization (IVF) and surrogacy, which is creating a positive market outlook.
In addition to this, governments of several countries are increasingly supporting genetic research and testing, thereby catalyzing the growth of the market.
However, the high cost of genetic testing and lack of awareness about genetic disorders among women are some of the
A customized collection of grant news from foundations and the federal government from around the Web.
In the world of social enterprises, failure is a cringe-worthy moment nobody wants to talk about. But, social entrepreneurs can benefit from their failures.